BU-NOT-SET

CONTACT US
Unlocking the potential of RNA therapeutics through innovation and collaboration
  • Biologics
RNA
Insight
Using in vitro release testing (IVRT) to analyse semi-solid topical formulations
  • Analytical chemistry
Cream squeezed out of a tube
White paper
Enhancing the production of RNA with continuous manufacturing
  • Biologics
Continuous manufacturing of RNA
Insight
GERTEIS MINI-PACTOR® Advanced dry granulation services
  • Drug product
GERTEIS MINI-PACTOR®
Fact sheet
Overcoming oncolytic virus therapy production challenges through collaboration
  • Biologics
Oncolytic virus therapy production
Case study
Emerging trends set to impact drug development in 2024
  • Industry trends
Trends in drug development
Insight
Webinar: ATMPs in focus: Essential CMC strategies for every phase
  • Biologics
ATMPs in focus
Webinar
Trends set to make an impact on oral solid dose development in 2024
  • Drug product
  • Industry trends
Oral solid dose
Insight
Enhancing AAV therapy development and manufacture with a platform approach
  • Biologics
Enhancing AAV therapy
Insight
Insight
  • Analytical chemistry
  • Industry trends
An expert’s guide to analytical services
Insight
  • Drug product
  • Manufacturing
How Lyophilisation can help overcome mRNA stability challenges
Insight
  • Drug product
  • Manufacturing
How pre-filled syringes are changing drug delivery of biologics
Webinar
  • Drug product
Choosing the right sterile container for your drug product
Video
  • Manufacturing
ReciBioPharm is Advancing the Future of xRNA Manufacturing
Webinar
  • Biologics
  • Manufacturing
Faster, Smaller, Smarter: Intelligent Manufacturing of mRNA Through The Power of Process Analytical Technologies
Insight
  • Biologics
ReciBioPharm: The Economic Case for Continuous Manufacturing
Insight
  • Drug product
  • Manufacturing
The innovation bottleneck: Why drug development is so tough, and how connectivity and predictive analysis can overcome obstacles
Insight
  • Industry trends
What are the key trends shaping drug development in 2025?